NCT Number: NCT00432757
Evaluation of Efficacy and Safety of an Anti-Allergy Drug With a Contact Lens in Allergic Conjunctivitis
The purpose of this study is to evaluate the efficacy and safety of an anti-allergy drug with a contact lens compared to placebo in preventing ocular itching associated with allergic conjunctivitis
Looking for future studies?
Notify MeKey information
Conditions
Age range
8 year and older
Sex eligibility
All sexes
Study type
Interventional
Phase
Phase 3
Primary location
Los Angeles, California, United States
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- history of ocular allergies and a positive skin test reaction to cat hair, cat dander, grasses, ragweed, and/or trees within the past 24 months; successful soft contact lens wearer who has frequently worn contact lenses for at least one month or more
Exclusion criteria
- active ocular infection; clinically significant blepharitis; follicular conjunctivitis; pterygium; narrow angle glaucoma; dry eye syndrome; ocular surgery within past 6 months; pregnancy or lactation
Treatment and study plan
Primary outcomes
-
Ocular itching
Secondary outcomes
-
Conjunctival, ciliary, and episcleral redness; chemosis and mucous discharge; tearing and lid swelling
Sponsors and collaborators
Lead sponsor
Vistakon Pharmaceuticals
Industry
Registry information
Official study title
A Multi-Center, Randomized, Double-Masked, Placebo-Controlled Evaluation of the Efficacy and Safety of an Anti-Allergy Drug With a Contact Lens as Compared to Placebo in the Prevention of Allergic Conjunctivitis in a Population of Allergic Contact Lens Wearers
Important dates
- Study start
- 2007
- Study completion
- 2007
- First posted
- Feb 8, 2007
- Registry last updated
- Apr 9, 2009
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
The INVIGORATE 2 Trial: A Clinical Trial to Assess the Efficacy and Safety of Subjects With Seasonal Allergic Conjunctivitis
NCT05234554
Allergic Conjunctivitis, Conjunctival Diseases
Mississauga, Ontario, Canada
View Trial DetailsA Study to Demonstrate How Well REGN1908-1909 Works in Reducing Ocular Allergy Signs and Symptoms in Adult Participants With Cat Allergy
NCT06602726
Allergic Conjunctivitis, Conjunctival Diseases
Andover, Massachusetts, United States
View Trial DetailsA Study to Demonstrate the Effect of REGN5713-5715 on Reducing Ocular Allergy Signs and Symptoms in Adult Participants With Birch Pollen Allergy
NCT06602739
Allergic Conjunctivitis, Conjunctival Diseases
Andover, Massachusetts, United States
View Trial DetailsThe Effects of Ectoin® Allergy Nasal Spray and Ectoin® Allergy Eye Drops Compared to Placebo
NCT01471184
Allergic Conjunctivitis, Allergic Rhinitis
Mississauga, Ontario, Canada
View Trial Details